GO:0008420 RNA polymerase II CTD heptapeptide repeat phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008420 describes the enzymatic removal of phosphate groups from the heptapeptide repeat (YSPTSPS) of the RNA polymerase II largest subunit C-terminal domain (CTD) [1, 3].
• This phosphatase activity is essential for recycling RNA polymerase II between transcription cycles and for coordinating co-transcriptional RNA processing [1, 5].
• Key enzymes include yeast Fcp1, Ssu72, Rtr1, and mammalian HSPC129/CTDSP1, which target phospho-Ser2 and phospho-Ser5 residues [1, 2, 4, 6].
• Dysregulation of CTD phosphatases is linked to developmental disorders, cancer, and neurodegenerative diseases through altered gene expression programs.
• Studying GO:0008420 requires combining biochemical assays, phospho-specific antibodies, and CRISPR-based genetic models to dissect its roles in transcription [2, 8].
• EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models and library screening to accelerate functional studies of CTD phosphatases.
Description
RNA polymerase II (Pol II) is the enzyme responsible for transcribing protein-coding genes in eukaryotes. Its largest subunit contains a unique C-terminal domain (CTD) composed of tandem heptapeptide repeats with the consensus sequence YSPTSPS. The phosphorylation state of this CTD acts as a molecular switch that recruits different factors during transcription initiation, elongation, and termination. GO:0008420, RNA polymerase II CTD heptapeptide repeat phosphatase activity, refers to the enzymatic removal of phosphate groups from these repeats, a process critical for resetting Pol II for new rounds of transcription [1, 3]. This activity was first biochemically characterized in yeast, where a phosphatase was shown to dephosphorylate the CTD and recycle Pol II. Subsequent studies identified specific enzymes such as Fcp1, Ssu72, and Rtr1 that target distinct phospho-serine residues within the heptad [2, 6]. In mammals, HSPC129 (also known as CTDSP1) exhibits similar CTD phosphatase activity and influences gene expression programs. The dynamic interplay between kinases and phosphatases at the CTD is now recognized as a central regulatory layer in eukaryotic gene expression. For researchers, GO:0008420 represents a focal point for understanding how transcription is coupled to RNA processing, and how its perturbation contributes to human disease. This article synthesizes authoritative QuickGO annotations and verified PubMed literature to provide a research-grade overview of the mechanisms, key genes, and experimental strategies for studying this phosphatase activity.
RNA polymerase II CTD heptapeptide repeat phosphatase activity At A Glance
| GO ID | GO:0008420 |
|---|---|
| GO term | RNA polymerase II CTD heptapeptide repeat phosphatase activity |
| Ontology | molecular_function |
| Synonym | CTD phosphatase activity; RNA polymerase II carboxy-terminal domain phosphatase activity |
| Definition | Catalysis of the reaction: RNA polymerase II large subunit CTD heptapeptide repeat--phospho-L-serine/threonine (consensus YSPTSPS) + H2O = RNA polymerase II large subunit + phosphate. |
| Major function | Dephosphorylation of the RNA polymerase II CTD to regulate transcription cycle and RNA processing. |
| Substrates | Phosphorylated serine/threonine residues within the YSPTSPS repeats of the Pol II largest subunit. |
| Representative enzymes | Fcp1, Ssu72, Rtr1, HSPC129/CTDSP1 |
| Cellular context | Nucleus, associated with the transcription machinery and RNA processing complexes. |
What Is GO:0008420?
GO:0008420 is a molecular function term defined as the catalysis of the reaction: RNA polymerase II large subunit CTD heptapeptide repeat--phospho-L-serine/threonine (consensus YSPTSPS) + H2O = RNA polymerase II large subunit + phosphate. In simpler terms, it is the enzyme activity that removes phosphate groups from serine or threonine residues within the repetitive YSPTSPS sequence of the RNA polymerase II largest subunit. This activity is synonymous with CTD phosphatase activity and RNA polymerase II carboxy-terminal domain phosphatase activity.
Why Is RNA polymerase II CTD heptapeptide repeat phosphatase activity Important in Cell Biology?
GO:0008420 is crucial because the phosphorylation cycle of the RNA polymerase II CTD governs the recruitment of factors that couple transcription with mRNA capping, splicing, and polyadenylation. Phosphatases that catalyze this reaction ensure that Pol II can be recycled and that transcription termination occurs properly [1, 5]. Disruption of this activity leads to widespread changes in gene expression, and mutations in CTD phosphatases have been associated with human diseases including cancer and neurodevelopmental disorders.
• Controls the recycling of RNA polymerase II between transcription cycles.
• Regulates the transition from transcription initiation to elongation.
• Coordinates 3'-end formation and termination of RNA transcripts.
• Modulates co-transcriptional splicing and polyadenylation.
• Influences gene expression programs during development and differentiation.
• Dysregulation is linked to cancer through altered oncogene and tumor suppressor expression.
• Implicated in neurodegenerative diseases via transcriptional stress.
• Provides a target for chemical inhibitors that modulate transcription.
• Essential for maintaining genomic stability by preventing transcription-replication conflicts.
• Serves as a model for studying reversible protein phosphorylation in gene regulation.
What Happens During RNA polymerase II CTD heptapeptide repeat phosphatase activity?
Recognition of the phosphorylated CTD
In simple terms: The phosphatase enzyme finds and binds to the phosphorylated tail of RNA polymerase II.
The CTD of the RNA polymerase II largest subunit consists of repeated YSPTSPS sequences that become phosphorylated on Ser2 and Ser5 during transcription. CTD phosphatases specifically recognize these phosphorylated repeats through their catalytic domains. For example, the yeast phosphatase Fcp1 binds to the phosphorylated CTD and removes phosphates from Ser2 and Ser5. Structural and biochemical studies have shown that the catalytic domain of these enzymes contains a conserved DXDX(T/V) motif typical of the haloacid dehalogenase family.
Catalytic dephosphorylation
In simple terms: The enzyme removes the phosphate group from the serine or threonine residue.
Once bound, the phosphatase catalyzes the hydrolysis of the phosphoester bond, releasing inorganic phosphate and regenerating the unphosphorylated serine or threonine. This reaction is metal-dependent, often requiring Mg2+ or Mn2+ ions for activity. The catalytic mechanism involves a nucleophilic attack by an aspartate residue, forming a transient phospho-enzyme intermediate that is subsequently hydrolyzed. This step is essential for resetting the CTD to its hypophosphorylated state.
Recycling of RNA polymerase II
In simple terms: After dephosphorylation, RNA polymerase II can be reused for a new round of transcription.
Dephosphorylation of the CTD by phosphatases such as Fcp1 allows RNA polymerase II to dissociate from elongation factors and re-enter the initiation-competent pool. Cho et al. demonstrated that a protein phosphatase functions to recycle RNA polymerase II in yeast, highlighting the importance of this activity in maintaining transcription fidelity. This recycling is critical for rapid and efficient gene expression responses.
Coordination with transcription elongation and termination
In simple terms: The phosphatase activity helps coordinate the end of transcription and the processing of RNA.
Ssu72, a CTD phosphatase, plays a key role in the initiation-elongation transition and in 3'-end formation. Rosado-Lugo et al. showed that the Ssu72 phosphatase mediates the RNA polymerase II initiation-elongation transition in yeast. In vertebrates, Ssu72 regulates and coordinates 3'-end formation of RNAs transcribed by RNA polymerase II. Thus, CTD phosphatase activity is intimately linked to the proper termination and processing of transcripts.
Dual-specificity phosphatases and additional layers
In simple terms: Some phosphatases can remove phosphates from both serine and tyrosine residues, adding complexity.
Rtr1 is a dual-specificity phosphatase that dephosphorylates both Tyr1 and Ser5 on the RNA polymerase II CTD. This broadens the regulatory scope of CTD phosphatases beyond serine/threonine and suggests that they can fine-tune the CTD code at multiple residues. Such dual-specificity activity may be important for integrating signals from different kinase pathways.
Key Genes Involved in GO:0008420 RNA polymerase II CTD heptapeptide repeat phosphatase activity
The following genes encode proteins that exhibit RNA polymerase II CTD heptapeptide repeat phosphatase activity or directly regulate it, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FCP1 (yeast) | CTD phosphatase that recycles RNA polymerase II | Model for studying transcription recycling and phosphatase mechanism |
| SSU72 (yeast) | CTD phosphatase mediating initiation-elongation transition | Key regulator of transcription and 3'-end formation |
| RTR1 (yeast) | Dual-specificity phosphatase dephosphorylating Tyr1 and Ser5 | Insight into CTD code regulation and phosphatase diversity |
| CTDSP1 (human, HSPC129) | RNA polymerase II CTD phosphatase | Potential target in cancer and gene expression studies |
| CTDSP2 (human) | CTD phosphatase | Implicated in cell cycle and differentiation |
| CTDSPL (human) | CTD phosphatase-like | Candidate tumor suppressor |
| CTDP1 (human) | CTD phosphatase, subunit 1 | Mutations cause congenital cataracts facial dysmorphism neuropathy syndrome |
| CTDP1 (Fcp1 homolog) | Essential CTD phosphatase | Required for transcription and cell viability |
| PNUTS (human) | Regulatory subunit of PP1 phosphatase | Modulates CTD phosphorylation |
| PP1 (human) | Protein phosphatase 1 | Dephosphorylates CTD at Ser2 and Ser5 |
| PP2A (human) | Protein phosphatase 2A | Regulates CTD phosphorylation dynamics |
| SCP1 (human) | Small CTD phosphatase 1 | Neuronal gene silencing |
| SCP2 (human) | Small CTD phosphatase 2 | Neuronal differentiation |
| SCP3 (human) | Small CTD phosphatase 3 | Regulates RNA polymerase II activity |
| TFIIH (human) | Kinase complex that phosphorylates CTD | Opposes phosphatase activity |
| CDK7 (human) | Kinase that phosphorylates Ser5 | Counteracts CTD phosphatases |
| CDK9 (human) | Kinase that phosphorylates Ser2 | Balances phosphatase activity |
How Is RNA polymerase II CTD heptapeptide repeat phosphatase activity Regulated?
The activity of RNA polymerase II CTD phosphatases is regulated at multiple levels. Their expression levels can vary across tissues and developmental stages, and post-translational modifications such as phosphorylation can modulate their catalytic activity. Additionally, interaction with regulatory subunits, such as PNUTS for PP1, can target the phosphatase to specific genomic loci or alter substrate specificity. The balance between CTD kinases (e.g., CDK7, CDK9) and phosphatases is critical for proper transcription dynamics, and perturbations in this balance can lead to disease.
RNA polymerase II CTD heptapeptide repeat phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CTDP1 | Congenital cataracts facial dysmorphism neuropathy syndrome | Knockout or point-mutation in human cell lines or animal models |
| CTDSPL | Cancer (tumor suppressor candidate) | Overexpression and knockout in cancer cell lines |
| SSU72 | Transcription termination defects | Yeast knockout and human cell line knockdown [2, 8] |
| FCP1 | Essential for cell viability | Conditional knockout in yeast and mammalian cells |
| RTR1 | CTD code regulation | Point mutations in yeast to dissect dual-specificity |
Cancer
Altered expression of CTD phosphatases has been observed in various cancers. For instance, CTDSPL is considered a candidate tumor suppressor, and its downregulation may contribute to tumorigenesis. The dysregulation of CTD phosphorylation dynamics can lead to aberrant expression of oncogenes and tumor suppressors, highlighting the importance of GO:0008420 in cancer biology.
Neurodevelopmental disorders
Mutations in CTDP1, which encodes a CTD phosphatase, cause congenital cataracts facial dysmorphism neuropathy (CCFDN) syndrome, a rare autosomal recessive disorder characterized by developmental defects and peripheral neuropathy. This underscores the critical role of CTD phosphatases in human development and neuronal function.
Neurodegeneration
Transcriptional dysregulation is a common feature of neurodegenerative diseases. Impaired CTD phosphatase activity may contribute to the accumulation of aberrant transcripts and neuronal stress, although direct evidence is still emerging.
From RNA polymerase II CTD heptapeptide repeat phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of CTD phosphatase loss on transcription? | CRISPR knockout of FCP1 or SSU72 in yeast or human cells [1, 2] |
| How do point mutations in the catalytic domain affect activity? | CRISPR point mutation (e.g., DXDX motif) in CTDSP1 |
| What are the interactors of CTD phosphatases? | Knock-in of epitope tags (e.g., FLAG, HA) followed by mass spectrometry |
| Can overexpression of CTD phosphatase alter gene expression? | Doxycycline-inducible overexpression in human cell lines |
| Which genes are regulated by CTD phosphatase activity? | CRISPR library screening with RNA-seq readout |
| How does CTD phosphatase activity change during differentiation? | Knockout and rescue in stem cell models |
How to Study the RNA polymerase II CTD heptapeptide repeat phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro phosphatase assay | Catalytic activity of CTD phosphatase | Enzyme kinetics and inhibitor testing |
| Phospho-CTD Western blot | Levels of phosphorylated Ser2/Ser5 on Pol II | Monitoring cellular CTD phosphorylation |
| RNA-seq | Global gene expression changes | Transcriptional profiling after phosphatase knockout |
| ChIP-seq | Genome-wide binding of Pol II and phosphatases | Mapping transcription dynamics |
| Mass spectrometry | Protein-protein interactions | Identifying phosphatase complexes |
| CRISPR screening | Genes required for specific phenotypes | Functional genomics of CTD phosphatases |
| Immunofluorescence | Subcellular localization of phosphatases | Visualizing nuclear distribution |
| qRT-PCR | Specific transcript levels | Validating RNA-seq findings |
Biochemical phosphatase assays
In vitro phosphatase assays using recombinant CTD phosphatase and synthetic phospho-CTD peptides can directly measure catalytic activity. These assays typically use malachite green or fluorescent substrates to quantify phosphate release [3, 4].
Phospho-specific antibodies and Western blotting
Antibodies that recognize phosphorylated Ser2 or Ser5 of the RNA polymerase II CTD are widely used to monitor changes in CTD phosphorylation upon modulation of phosphatase activity. This method provides a semi-quantitative readout of cellular CTD phosphorylation states [2, 6].
RNA-seq and transcriptomics
RNA sequencing can reveal global changes in gene expression and alternative splicing patterns following knockout or knockdown of CTD phosphatases. This approach helps identify the transcriptional programs controlled by GO:0008420 [5, 8].
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify proteins that interact with CTD phosphatases, shedding light on their regulatory complexes and substrates. This is particularly useful for understanding how phosphatases are targeted to specific genes.
How CRISPR Can Be Used to Study GO:0008420 RNA polymerase II CTD heptapeptide repeat phosphatase activity
Knockout
CRISPR knockout of CTD phosphatase genes such as FCP1, SSU72, or CTDSP1 allows researchers to study loss-of-function phenotypes. For essential genes, conditional or inducible knockout systems are necessary to avoid lethality [1, 2].
Point Mutation
Introducing point mutations in the catalytic domain (e.g., DXDX motif) of CTD phosphatases via CRISPR can dissect the contribution of enzymatic activity versus scaffolding functions. This is particularly useful for separating phosphatase-dependent and independent roles.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins at the endogenous locus enables real-time tracking and affinity purification of CTD phosphatases. This approach preserves endogenous regulation and can reveal dynamic localization.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can be used to increase CTD phosphatase levels, allowing gain-of-function studies. This is valuable for testing whether elevated phosphatase activity alters transcription and cellular phenotypes.
How EDITGENE Supports RNA polymerase II CTD heptapeptide repeat phosphatase activity Research
Researchers studying RNA polymerase II CTD heptapeptide repeat phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in transcription regulation or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this functional validation.
Contact EDITGENE today to design your custom CRISPR model for RNA polymerase II CTD heptapeptide repeat phosphatase activity research.
Frequently Asked Questions About RNA polymerase II CTD heptapeptide repeat phosphatase activity
What is RNA polymerase II CTD heptapeptide repeat phosphatase activity?
It is the enzymatic activity that removes phosphate groups from the heptapeptide repeats (YSPTSPS) of the RNA polymerase II largest subunit, as defined by GO:0008420 [1, 3].
What genes are involved in RNA polymerase II CTD heptapeptide repeat phosphatase activity?
Key genes include FCP1, SSU72, RTR1 in yeast, and CTDSP1, CTDSP2, CTDSPL, CTDP1 in humans [1, 2, 4, 6].
Why is CTD phosphatase activity important for transcription?
It recycles RNA polymerase II and coordinates transcription termination and RNA processing, ensuring proper gene expression [1, 5].
How is RNA polymerase II CTD phosphatase activity regulated?
It is regulated by expression levels, post-translational modifications, and interaction with regulatory subunits like PNUTS.
What diseases are associated with CTD phosphatase dysfunction?
Mutations in CTDP1 cause CCFDN syndrome, and altered expression of CTD phosphatases is linked to cancer and neurodegeneration.
What methods are used to study CTD phosphatase activity?
Biochemical assays, phospho-specific Western blots, RNA-seq, ChIP-seq, and CRISPR screens are commonly used [2, 3, 5, 8].
Can CRISPR be used to study CTD phosphatases?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect their functions [1, 4, 5].
What is the role of Ssu72 in transcription?
Ssu72 is a CTD phosphatase that mediates the initiation-elongation transition and regulates 3'-end formation [2, 8].
How does Fcp1 function in RNA polymerase II recycling?
Fcp1 dephosphorylates the CTD, allowing RNA polymerase II to be reused for new transcription cycles.
What is the clinical relevance of CTD phosphatase research?
It provides insights into transcriptional regulation and potential therapeutic targets for cancer and neurodevelopmental disorders.
Conclusion
GO:0008420, RNA polymerase II CTD heptapeptide repeat phosphatase activity, is a fundamental molecular function that controls the phosphorylation cycle of RNA polymerase II. Through the action of enzymes like Fcp1, Ssu72, and CTDSP1, it ensures proper transcription recycling, RNA processing, and gene expression. Dysregulation of this activity is linked to human diseases, making it a compelling area of research. Leveraging CRISPR-based models and advanced screening technologies, researchers can now dissect the precise roles of CTD phosphatases in health and disease.
References
- 1. Cho H et al.. 1999. A protein phosphatase functions to recycle RNA polymerase II.. Genes Dev 13(12):1540-52 PMID: 10385623
- 2. Rosado-Lugo JD et al.. 2014. The Ssu72 phosphatase mediates the RNA polymerase II initiation-elongation transition.. J Biol Chem 289(49):33916-26 PMID: 25339178
- 3. Chambers RS et al.. 1996. Purification and characterization of an RNA polymerase II phosphatase from yeast.. J Biol Chem 271(40):24498-504 PMID: 8798710
- 4. Qian H et al.. 2007. Expression and characterization of HSPC129, a RNA polymerase II C-terminal domain phosphatase.. Mol Cell Biochem 303(1-2):183-8 PMID: 17487459
- 5. González-Jiménez A et al.. 2026. RNA polymerase II phosphorylation dynamics: from molecular mechanisms to human disease.. RNA Biol 23(1):1-20 PMID: 42370638
- 6. Hsu PL et al.. 2014. Rtr1 is a dual specificity phosphatase that dephosphorylates Tyr1 and Ser5 on the RNA polymerase II CTD.. J Mol Biol 426(16):2970-81 PMID: 24951832
- 7. Hirose Y et al.. 2007. Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression.. J Biochem 141(5):601-8 PMID: 17405796
- 8. Wani S et al.. 2014. Vertebrate Ssu72 regulates and coordinates 3'-end formation of RNAs transcribed by RNA polymerase II.. PLoS One 9(8):e106040 PMID: 25166011
